¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"membranous lipodystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membranous lipodystrophy
    ¸·Áö¹æÀÌ»óÁõ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lipodystrophy
    Áö¹æÀÌ»óÁõ, Áö¹æµð½ºÆ®·ÎÇÇ
  • membranous bone graft
    ¸·»ÀÀ̽Ä, ¸·¼º°ñÀ̽Ä
  • membranous capacitance
    ¼¼Æ÷¸·Àü±â¿ë·®
  • membranous cataract
    ¸·¸ð¾ç¹é³»Àå
  • membranous cochlea
    ¸·¼º´ÞÆØÀÌ
  • membranous colitis
    ¸·Àß·ÏâÀÚ¿°, ¸·°áÀå¿°
  • membranous conjunctivitis
    ¸·°á¸·¿°
  • membranous croup
    ¸·¼ºÅ©·çÇÁ
  • membranous dysmenorrhea
    ¸·¼º¿ù°æÅë
  • membranous endometritis
    ¸·Àڱ󻸷¿°
  • membranous glomerulonephritis
    ¸·Å丮ÄáÆÏ¿°, ¸·»ç±¸Ã¼½Å¿°
  • membranous inflammation
    ¸·¼º¿°Áõ
  • membranous labyrinth
    ¸·¹Ì·Î
  • membranous lamina
    ¸·ÆÇ
  • membranous laryngitis
    ¸·Èĵο°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membranous glomerulonephritis
    ¸·Å丮ÄáÆÏ¿°, ¸·»ç±¸Ã¼½Å¿°
  • membranous nephropathy
    ¸·¼ºÄáÆÏº´Áõ
  • membranous vestibule
    ¸·¾È¶ã
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membranous lipodystrophy
    ¸·Áö¹æÀÌ»óÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lipodystrophy
    Áö¹æÀÌ»óÁõ
  • membranous cataract
    ¸·¸ð¾ç¹é³»Àå
  • membranous cochlea
    (¢¡cochlear duct) ´ÞÆØÀ̰ü
  • membranous colitis
    ¸·Àß·èâÀÚ¿°, ¸·°áÀå¿°
  • membranous conjunctivitis
    ¸·°á¸·¿°
  • membranous croup
    (¢¡laryngeal croup) ÈĵÎÅ©·ì, »ó±âµµ¸·ÈûÁõ
  • membranous desquamation
    ¸·¼º»óÇǹþÀ½
  • membranous disc
    ¸·¿ø¹Ý
  • membranous dysmenorrhea
    Å»¸·¿ù°æÅë
  • membranous endometritis
    ¸·Àڱ󻸷¿°
  • membranous glomerulonephritis
    ¸·Å丮ÄáÆÏ¿°, ¸·»ç±¸Ã¼½Å¿°
  • membranous inflammation
    ¸·¿°Áõ
  • membranous labyrinth
    ¸·¹Ì·Î
  • membranous lamina
    ¸·¼ºÆÇ
  • membranous laryngitis
    ¸·Èĵο°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lamellar membranous boneSecondary membranous bone
    ÃþÆÇ¸·»ÀÀÌÂ÷¸·»À
  • generalized lipodystrophy
    Àü½Å¼º Áö¹æÀÌ¿µ¾çÁõ
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ.
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ(òäú¼àõ ò·Û¸ì¶ç½å×ñø)
  • glomerulonephritis,membranous
    ¸·¼º
  • pharyngitis, membranous
    ¸·(¼º)Àεο°
  • posterior membranous ampulla ³ª a. membranacea p.
    µÚ¸·ÆØ´ë, Èĸ·ÆØ´ë ºÎ(ý­Ø¯ø³ÓÞÝ»).
  • posterior membranous ampulla ³ª a. membranacea p.
    µÚ¸·ÆØ´ë, Èĸ·ÆØ´ë ºÎ(ý­Ø¯ø³ÓÞÝ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membranous lipodystrophy = membranous lipoatrophy
    ¸·¼ºÁö¹æÀÌ¿µ¾çÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lamellar membranous bone secondary membranous bone
    ÃþÆÇ¸·»À ÀÌÂ÷¸·»À
  • reticulofibrous membranous bone [primary membranous bone]
    ¼¼¸Á¼¶À¯¸·»À (ÀÏÂ÷¸·»À)
  • reticulofibrous membranous bone[primary membranous bone]
  • centrifugal lipodystrophy
    ¿ø½É Áö¹æ ÀÌ¿µ¾çÁõ
  • dystrophy (intestinal lipodystrophy)
    ¿µ¾çÀå¾Ö(âÀÚÁö¹æ¿µ¾çÀå¾Ö)
  • generalized lipodystrophy
    Àü½Å¼º Áö¹æÀÌ¿µ¾çÁõ
  • insulin lipodystrophy
    Àν¶¸°Áö¹æÀÌ¿µ¾çÁõ.
  • intestinal lipodystrophy =Whipple s disease
    À强Áö¹æÀÌ¿µ¾çÁõ.
  • lipodystrophy, lipodystrophia ³ª
    Áö¹æÀÌ¿µ¾çÁõ(ò·Û¸ì¶ç½å×ñø)
  • lipodystrophy, partial
    ºÎºÐÁö¹æÀÌ¿µ¾çÁõ.
  • partial lipodystrophy
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ.
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ(òäú¼àõ ò·Û¸ì¶ç½å×ñø)
  • canal, membranous cochlear
    ¸·(¼º)¿Í¿ì°ü
  • canal, membranous semicircular
    ¸·(¼º)¹Ý±Ô°ü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Reticulofibrous membranous bone [Primary membranous bone]
    ¼¼¸Á¼¶À¯¸·»À [ÀÏÂ÷¸·»À]
    [¿¾ ¿ë¾î] ÀÏÂ÷¸·¼º°ñ
  • Lamellar membranous bone [Secondary membranous bone]
    ÃþÆÇ¸·»À [ÀÌÂ÷¸·»À]
    [¿¾ ¿ë¾î] ÀÌÂ÷¸·¼º°ñ
  • Membranous wall
    °í¸·º®
    [¿¾ ¿ë¾î] °í¸·º®
  • Membranous labyrinth
    ¸·¹Ì·Î
    [¿¾ ¿ë¾î] ¸·¼º¹Ì·Î
  • Membranous wall
    ¸·º®
    [¿¾ ¿ë¾î] ¸·»óº®
  • Membranous wall
    ¸·º®
    [¿¾ ¿ë¾î] ¸·¼ºº®
  • Membranous part
    ¸·ºÎºÐ
    [¿¾ ¿ë¾î] °Ý¸·ºÎ
  • Membranous part
    ¸·ºÎºÐ
    [¿¾ ¿ë¾î] ¸·ºÎ
  • Membranous part
    ¸·ºÎºÐ
    [¿¾ ¿ë¾î] ¸·¼ººÎ
  • Defect of membranous part
    ¸·ºÎºÐ°áÇÔ
    [¿¾ ¿ë¾î] ¸·¼ººÎ°áÇÔ
  • Membranous bone
    ¸·»À
    [¿¾ ¿ë¾î] ¸·¼º°ñ
  • Membranous bone development
    ¸·»À¹ß»ý
    [¿¾ ¿ë¾î] ¸·¼º°ñ¹ß»ý
  • Membranous ossification
    ¸·»À¹ß»ý
    [¿¾ ¿ë¾î] ¸·¼º°ñ¹ß»ý
  • Membranous lamina
    ¸·¼ºÆÇ
    [¿¾ ¿ë¾î] ¸·¼ºÆÇ
  • Membranous disc
    ¸·¿ø¹Ý
    [¿¾ ¿ë¾î] ¸·¼ºÃþÆÇ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membranous
    ¸·¼ºÀÇ
  • membranous bone
    ¸·°ñ
  • membranous enteritis
    ¸·¼ºÀå¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MN a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt...
LD labor and delivery; laboratory data; labyrinthine defect; lactate dehydrogenase; laser Doppler; lear...
MGN Membranous Glomerulo-Nephritis(Nephropathy)
MN   1) Membranous Nephropathy
  2) Mid-Night; ÀÚÁ¤
PMC Pseudo-Membranous Colitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FPLD Familial partial lipodystrophy
LD Lipodystrophy
IMN Idiopathic Membranous Nephropathy
iMGN Idiopathic membranous glomerulonephritis
M Membranous
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • membranous lipodystrophy
    ¸·¼º Áö¹æ ÀÌ¿µ¾çÁõ
    µ¿ÀǾî=membranous li
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • centrifugal lipodystrophy
    ¿ø½É Áö¹æ ÀÌ¿µ¾çÁõ
  • lamellar membranous bone
    ÃþÆÇ ¸·
  • maculae of membranous labyrinth
    ¸· ¹Ì·Î¹Ý
    µ¿ÀǾî=maculae saculi.
  • membranous
    ¸·¼ºÀÇ
  • membranous cochlear canal
    ¸· ¿Í¿ì °ü, ¸·¼º ¿Í¿ì °ü
  • membranous ossification
    ¸·¼º °ñÈ­
  • membranous semicircular canal
    ¸· ¹Ý±Ô°ü, ¸·¼º ¹Ý±Ô°ü
  • membranous wall
    ¸·¼º º®
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
membranous lipodystrophy A rare metabolic disease in which bone marrow fat cells are transformed into thick convoluted PAS-staining membranes enclosing weakly osmophilic material; leads to progressive cystic resorption of limb bones and dementia with sudanophilic leukodystrophy.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
partial face-sparing lipodystrophy A syndrome beginning at puberty that resembles total lipodystrophy but is inherited as an autosomal or X-linked dominant form.
(05 Mar 2000)
congenital total lipodystrophy Lipodystrophy characterised by almost complete lack of subcutaneous fat, accelerated rate of growth and skeletal development during the first 3 to 4 years of life, muscular hypertrophy, cardiac enlargement, hepatosplenomegaly, hypertrichosis, renal enlargement, hypertriglyceridemia, and hypermetabolism; both autosomal dominant and X-linked varieties exist.
(05 Mar 2000)
progressive lipodystrophy A condition characterised by a complete loss of the subcutaneous fat of the upper part of the torso, the arms, neck, and face, sometimes with an increase of fat in the tissues about and below the pelvis.
Synonym: Barraquer's disease, lipodystrophia progessiva superior, partial lipoatrophy, Simons' disease.
(05 Mar 2000)
insulin lipodystrophy Dystrophic atrophy of subcutaneous tissues in diabetics at the site of frequent injections of insulin.
Synonym: insulin lipoatrophy.
(05 Mar 2000)
intestinal lipodystrophy <gastroenterology> A rare disorder of intestinal malabsorption that occurs as the result of the intestine. Treatment is with antibiotics.
(27 Sep 1997)
familial lipodystrophy Autosomal dominant; partial lip associated with multifacial hypoplasin, retarded bone age, and hypotichosis.
(05 Mar 2000)
lipodystrophy 1. <biochemistry> Any disturbance of fat metabolism.
2. A group of conditions due to defective metabolism of fat, resulting in the absence of subcutaneous fat, which may be congenital or acquired and partial or total.
Synonym: lipoatrophy, lipodystrophia.
(18 Nov 1997)
glomerulonephritis, membranous A disease of the glomerulus manifested clinically by proteinuria, and sometimes by other features of the nephrotic syndrome. It is histologically characterised by deposits in the glomerular capillary wall between the epithelial cell and the basement membrane and a thickening of the membrane. Also characteristic are outward projections of the membrane between the epithelial deposits in the form of "spikes". There is some agreement that the deposits are antigen-antibody complexes.
(12 Dec 1998)
membranous Having a thin, soft, pliable texture.
(09 Oct 1997)
membranous ampulla A nearly spherical enlargement of one end of each of the three saemicircular ducts, anterior, posterior, and lateral, where they connect with the utricle. Each contains a neuroepithelial crista ampullaris.
Synonym: ampulla membranacea, membranous ampulla.
(05 Mar 2000)
membranous cataract A secondary cataract composed of the remains of the thickened capsule and degenerated lens fibres.
(05 Mar 2000)
membranous cochlea Spiral tube in the bony canal of the cochlea, lying on its outer wall between the scala vestibuli and scala tympani.
(12 Dec 1998)
membranous conjunctivitis A severe conjunctival inflammation caused by Corynebacterium diphtheriae and characterised by an infiltrating membrane which on removal leaves a raw surface.
Synonym: membranous conjunctivitis.
(05 Mar 2000)
membranous dysmenorrhoea Dysmenorrhoea accompanied by an exfoliation of the menstrual decidua.
(05 Mar 2000)
membranous glomerulonephritis <pathology> A kidney disease that occurs due to inflammation of the kidney glomerulus and its basement membrane.
The exact cause is unknown but it appears to be related to the deposition of immune complexes in the basement membrane leading to thickening of the capillary walls. This disorder is a common cause of nephrotic syndrome an is usually how the disease manifests.
Risk factors include primary renal disease, malaria, hepatitis B, lupus, syphilis, cancers and non-Hodgkin's lymphomas. Risks also include exposure to some medications such as gold compounds and penicillamine. Mercury, trimethadione and some skin-lightening creams have also been implicated.
Treatment includes systemic corticosteroids and immunosuppressive agents.
(26 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membranous
    ¸· ¸ð¾çÀÇ;¸·À» Çü¼ºÇÏ´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á